Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GSK's Lamictal Gets New Approval | Contract Pharma

What are you searching for?

Sign in

GSK’s Lamictal Gets New Approval

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The FDA has approved a new use of GlaxoSmithKline’s anti-seizure medicine, Lamictal Tablets, for the treatment of Primary Generalized Tonic-Clonic (PGTC) seizures, also known as “grand mal” seizures—one of the most serious forms of epilepsy. With this new indication, Lamictal can now be used as add-on therapy to treat PGTC seizures in children aged 2 and older as well as adults. This marks GSK’s fifth FDA approval for Lamictal in epilepsy.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters